Register to leave comments

  • News bot July 29, 2026, 1:02 p.m.

    📋 PULSE BIOSCIENCES, INC. (PLSE) - Clinical Trial Update

    Filing Date: 2026-07-29

    Accepted: 2026-07-29 09:01:54

    Event Type: Clinical Trial Update

    Event Details:

    PULSE BIOSCIENCES, INC. (PLSE) Announces Clinical Trial Update PULSE BIOSCIENCES, INC. (PLSE) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: study, seeing
    • Diseases/Conditions: pulmonary vein isolation
    • Clinical Stage: Pivotal Study
    • Collaboration: IDE

    🔬 Clinical Development Pipeline (PULSE BIOSCIENCES, INC.):

    Product Type Development Stage Therapeutic Area Source
    CellFX nsPFA Cardiac Catheter System Other Approved Atrial Fibrillation Paroxysmal ClinicalTrials.gov
    CellFX nano-pFA 360 Endocardial Ablation Catheter System Other Approved Atrial Fibrillation Paroxysmal ClinicalTrials.gov
    Nano-Pulse Stimulation (NPS) Other Approved Sebaceous Hyperplasia ClinicalTrials.gov
    Pulse Therapeutics (PTI) Magnetically-Enhanced Diffusion (MED) Other Phase PHASE1 Ischemic Stroke ClinicalTrials.gov
    Observational Chickpea Diet Other Preclinical Inflammation ClinicalTrials.gov
    Chickpea Enhanced Diet (Short term) Other Approved Inflammation ClinicalTrials.gov
    CellFX System Other Approved BCC - Basal Cell Carcinoma ClinicalTrials.gov
    CellFX Device Device Approved Warts ClinicalTrials.gov
    Cryosurgery Liquid Nitrogen Sprayer Procedure Approved Warts ClinicalTrials.gov
    CellFX System Device Device Approved Warts ClinicalTrials.gov
    Nano-Pulse Stimulation Device Device Approved Skin Lesion ClinicalTrials.gov
    Intralesional Electrodesiccation Other Approved Skin Lesion ClinicalTrials.gov
    CellFX® Percutaneous Electrode (PE) System Other Approved Thyroid Nodule (Benign) ClinicalTrials.gov
    CellFX® nsPFA™ Cardiac Surgery System Procedure Approved Atrial Fibrillation ClinicalTrials.gov
    nPulse Vybrance Percutaneous Electrode System Other Approved Thyroid Nodule ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PULSE BIOSCIENCES, INC.
    • Ticker Symbol: PLSE